This podcast series from the Academy's Committee on Aging features leading experts who discuss clinical experiences and the differences in caring for older adults.

In this podcast, Dr. Neil Bressler leads a discussion on the management of patients with age-related macular degeneration. The participants consider a range of issues, including their approach to antibiotic use, the real-world implication of the published CATT outcomes, and the challenge of motivating patients who may be discouraged by a long-term regimen of intravitreal injections.

Financial Disclosures: Dr. Bressler discloses that he receives consulting fees or grant support from Abbott Medical Optics, Alimera, Allergan, Bausch & Lomb Surgical, Carl Zeiss Meditec, DIAGNOS, the EMMES Corporation, ForSight Labs, Genentech, Genzyme, Lumenis, Notal Vision, Novartis Pharmaceuticals, Pfizer, Quark Biotech, Regeneron, Research to Prevent Blindness, and Steba Biotech. Dr. Kim discloses that she receives consulting fees or grant support from Alimera, Allergan, Genentech, the National Eye Institute, and Regeneron. Dr. Lim discloses that she receives consulting fees or grant support from Genentech, Icon Bioscience, Quark Biotech, and Regeneron.